Rejoni

Healthcare SpecialistsSeries BBedford, USrejoni.com

Latest round

Series B

Last raised

Jun 2026

Total raised

$65M

Investors

8

About Rejoni

Rejoni, Inc.Founded in 2020 and headquartered in Bedford, US, Rejoni, Inc. focuses on developing medical technologies to improve women's reproductive health.250 mn.Rejoni™ specializes in developing innovative solutions for women's reproductive health, focusing on preventing intrauterine adhesions, commonly known as Asherman's Syndrome, which can arise following uterine procedures. Their primary product, Juveena™ Hydrogel, is designed to be instilled into the uterus immediately after surgical interventions such as fibroid removal or adhesiolysis, with the intent of minimizing scar tissue formation. By addressing the critical issue of intrauterine adhesions, Rejoni aims to improve women’s health outcomes by reducing associated complications such as menstrual irregularities and pregnancy losses.Rejoni™ operates on a revenue model primarily driven by clinical trial partnerships and the eventual commercialization of its flagship product, Juveena™ Hydrogel. The company engages with healthcare providers and clinical institutions to facilitate its research initiatives, which may involve service contracts or collaborations that allow for the testing and evaluation of the hydrogel in clinical settings. Revenue generation is anticipated to grow as Juveena™ Hydrogel progresses through the trial phases and moves toward regulatory approval, leading to potential direct sales to medical facilities and practitioners. The business structure emphasizes B2B relationships, focusing on partnerships with healthcare providers who will administer the product and potentially incorporate it into their surgical protocols once it receives market authorization. In June 2026, Rejoni, Inc.

Who invested in Rejoni

8 investors across 3 rounds

See all investors in Rejoni

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 16, 2026

    Amount

    $25M

    Investors

    Locked

  2. Series B

    Dec 7, 2022

    Amount

    $25M

    Investors

    Locked

  3. Series A

    Sep 4, 2020

    Amount

    $15M

    Investors

    Locked

Questions about Rejoni

Who invested in Rejoni?

Rejoni has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Rejoni raised?

Rejoni has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Rejoni last raise money?

Rejoni's most recent round on record is a Series B, in Jun 2026.

What does Rejoni do?

Rejoni is a healthcare specialists company.

Where is Rejoni headquartered?

Rejoni is headquartered in Bedford, US.

Which VCs invest in companies like Rejoni?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Rejoni's stage. Their profiles are linked below.

Raising like Rejoni? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.